Depression and clinical progression in spinocerebellar ataxias

Parkinsonism and Related Disorders

Volumn 22, Issue , 2016, Pages 87-92

  Lo, Raymond Y ^a   Figueroa, Karla P ^b   Pulst, Stefan M ^b   Perlman, Susan ^c   Wilmot, George ^d   Gomez, Christopher ^e   Schmahmann, Jeremy ^f   Paulson, Henry ^g   Shakkottai, Vikram G ^g   Ying, Sarah ^h   Zesiewicz, Theresa ⁱ   Bushara, Khalaf ^j   Geschwind, Michael ^k   Xia, Guangbin ^l   Yu, Jui Tsen ^m   Lee, Lue En ^m   Ashizawa, Tetsuo ^l   Subramony, S H ^l   Kuo, Sheng Han ^m  

^a TZU CHI UNIVERSITY   (Taiwan)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF SOUTH FLORIDA   (United States)

^j UNIVERSITY OF MINNESOTA   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l UNIVERSITY OF FLORIDA   (United States)

^m NONE   (United States)

more..

Author keywords

Cerebellum; Depression; Neurodegeneration; Spinocerebellar ataxias; Suicide

Indexed keywords

ADULT; ARTICLE; CAG REPEAT; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; FEMALE; FUNCTIONAL STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; PATIENT HEALTH QUESTIONNAIRE 9; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; SARA SCORE; SCALE FOR ASSESSMENT AND RATING OF ATAXIA; SCORING SYSTEM; SPINOCEREBELLAR DEGENERATION; SUICIDAL IDEATION; UNIFIED HUNTINGTON DISEASE RATING SCALE; AGED; DISEASE COURSE; MACHADO-JOSEPH DISEASE; MIDDLE AGED; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; SPINOCEREBELLAR ATAXIAS;

ADULT; AGED; COMORBIDITY; DEPRESSION; DISEASE PROGRESSION; FEMALE; HUMANS; MACHADO-JOSEPH DISEASE; MALE; MIDDLE AGED; PREVALENCE; SEVERITY OF ILLNESS INDEX; SPINOCEREBELLAR ATAXIAS; SUICIDAL IDEATION;

EID: 84952870564     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2015.11.021     Document Type: Article

References (35)

1. Ashizawa T., Figueroa K.P., Perlman S.L., Gomez C.M., Wilmot G.R., Schmahmann J.D., et al. Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study. Orphanet J. Rare Dis. 2013, 8:177.
2. Jacobi H., Bauer P., Giunti P., Labrum R., Sweeney M.G., Charles P., et al. The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study. Neurology 2011, 77:1035-1041.
3. Moscovich M., Okun M.S., Favilla C., Figueroa K.P., Pulst S.M., Perlman S., et al. Clinical evaluation of eye movements in spinocerebellar ataxias: a prospective multicenter study. J. Neuroophthalmol. 2015, 35:16-21.
4. Seidel K., Siswanto S., Brunt E.R., den Dunnen W., Korf H.W., Rüb U. Brain pathology of spinocerebellar ataxias. Acta Neuropathol. 2012, 124:1-21.
5. Tezenas du Montcel S., Dürr A., Bauer P., Figueroa K.P., Ichikawa Y., Brussino A., et al. Modulation of the age at onset in spinocerebellar ataxia by CAG tracts in various genes. Brain 2014, 137:2444-2455.
6. Nelson D.L., Orr H.T., Warren S.T. The unstable repeats-three evolving faces of neurological disease. Neuron 2013, 77:825-843.
7. Orr H.T., Chung M.Y., Banfi S., Kwiatkowski T.J., Servadio A., Beaudet A.L., et al. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat. Genet. 1993, 4:221-226.
8. Schöls L., Amoiridis G., Büttner T., Przuntek H., Epplen J.T., Riess O. Autosomal dominant cerebellar ataxia: phenotypic differences in genetically defined subtypes?. Ann. Neurol. 1997, 42:924-932.
9. Stevanin G., Durr A., Brice A. Clinical and molecular advances in autosomal dominant cerebellar ataxias: from genotype to phenotype and physiopathology. Eur. J. Hum. Genet. 2000, 8:4-18.
10. Chaudhuri K.R., Schapira A.H. Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol. 2009, 8:464-474.
11. Pla P., Orvoen S., Saudou F., David D.J., Humbert S. Mood disorders in Huntington's disease: from behavior to cellular and molecular mechanisms. Front. Behav. Neurosci. 2014, 8:135.
12. Schmitz-Hübsch T., Coudert M., Tezenas du Montcel S., Giunti P., Labrum R., Dürr A., et al. Depression comorbidity in spinocerebellar ataxia. Mov. Disord. 2011, 26:870-876.
13. Kawai Y., Takeda A., Abe Y., Washimi Y., Tanaka F., Sobue G. Cognitive impairments in Machado-Joseph disease. Arch. Neurol. 2004, 61:1757-1760.
14. McMurtray A.M., Clark D.G., Flood M.K., Perlman S., Mendez M.F. Depressive and memory symptoms as presenting features of spinocerebellar ataxia. J. Neuropsychiatry Clin. Neurosci. 2006, 18:420-422.
15. Braga-Neto P., Pedroso J.L., Alessi H., Dutra L.A., Felício A.C., Minett T., et al. Cerebellar cognitive affective syndrome in Machado Joseph disease: core clinical features. Cerebellum 2012, 11:549-556.
16. Klinke I., Minnerop M., Schmitz-Hübsch T., Hendriks M., Klockgether T., Wüllner U., et al. Neuropsychological features of patients with spinocerebellar ataxia (SCA) types 1, 2, 3, and 6. Cerebellum 2010, 9:433-442.
17. Cecchin C.R., Pires A.P., Rieder C.R., Monte T.L., Silveira I., Carvalho T., et al. Depressive symptoms in Machado-Joseph disease (SCA3) patients and their relatives. Community Genet. 2007, 10:19-26.
18. Suenaga M., Kawai Y., Watanabe H., Atsuta N., Ito M., Tanaka F., et al. Cognitive impairment in spinocerebellar ataxia type 6. J. Neurology, Neurosurg. Psychiatry 2008, 79:496-499.
19. Zawacki T.M., Grace J., Friedman J.H., Sudarsky L. Executive and emotional dysfunction in Machado-Joseph disease. Mov. Disord. 2002, 17:1004-1010.
20. Schmahmann J.D., Sherman J.C. The cerebellar cognitive affective syndrome. Brain 1998, 121:561-579.
21. Kim J.I., Long J.D., Mills J.A., McCusker E., Paulsen J.S. Multivariate Clustering of Progression Profiles Reveals Different Depression Patterns in Prodromal Huntington Disease. Neuropsychology 2015, 29:949-960. PREDICT-HD Investigators and Coordinators of the Huntington Study Group.
22. Sommerauer M., Valko P.O., Werth E., Poryazova R., Hauser S., Baumann C.R. Revisiting the impact of REM sleep behavior disorder on motor progression in Parkinson's disease. Park. Relat. Disord. 2014, 20:460-462.
23. Almeida-Silva U.C., Hallak J.E., Júnior W.M., Osório Fde L. Association between spinocerebellar ataxias caused by glutamine expansion and psychiatric and neuropsychological signals - a literature review. Am. J. Neurodegener. Dis. 2013, 2:57-69.
24. Fancellu R., Paridi D., Tomasello C., Panzeri M., Castaldo A., Genitrini S., et al. Longitudinal study of cognitive and psychiatric functions in spinocerebellar ataxia types 1 and 2. J. Neurol. 2013, 260:3134-3143.
25. Le Pira F., Giuffrida S., Maci T., Marturano L., Tarantello R., Zappalà G., et al. Dissociation between motor and cognitive impairments in SCA2: Evidence from a follow-up study. J. Neurol. 2007, 254:1455-1456.
26. Lo R.Y., Figueroa K.P., Pulst S.M., Lin C.Y., Perlman S., Wilmot G., et al. Coenzyme Q10 and spinocerebellar ataxias. Mov. Disord. 2015, 30:214-220.
27. Lo R.Y., Figueroa K.P., Pulst S.M., Lin C.Y., Perlman S., Wilmot G., et al. Vascular risk factors and clinical progression in spinocerebellar ataxias. Tremor Other Hyperkinet Mov. (N Y) 2015, 5:287.
28. Kroenke K., Spitzer R.L., Williams J.B. The PHQ-9: validity of a brief depression severity measure. J. Gen. Intern Med. 2001, 16:606-613.
29. Löwe B., Spitzer R.L., Gräfe K., Kroenke K., Quenter A., Zipfel S., et al. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians' diagnoses. J. Affect Disord. 2004, 78:131-140.
30. Schulberg H.C., Lee P.W., Bruce M.L., Raue P.J., Lefever J.J., Williams J.W., et al. Suicidal ideation and risk levels among primary care patients with uncomplicated depression. Ann. Fam. Med. 2005, 3:523-528.
31. Simon G.E., Rutter C.M., Peterson D., Oliver M., Whiteside U., Operskalski B., et al. Does response on the PHQ-9 Depression Questionnaire predict subsequent suicide attempt or suicide death?. Psychiatr. Serv. 2013, 64:1195-1202.
32. Stoodley C.J., Schmahmann J.D. Evidence for topographic organization in the cerebellum of motor control versus cognitive and affective processing. Cortex 2010, 46:831-844.
33. Tabrizi S.J., Scahill R.I., Dürr A., Roos R.A., Leavitt B.R., Jones R., et al. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol. 2011, 10:31-42.
34. Teixeira-Castro A., Jalles A., Esteves S., Kang S., da Silva Santos L., Silva-Fernandes A., et al. Serotonergic signalling suppresses ataxin 3 aggregation and neurotoxicity in animal models of Machado-Joseph disease. Brain 2015, 138:3221-3237.
35. Chollet F., Cramer S.C., Stinear C., Kappelle L.J., Baron J.C., Weiller C., et al. Pharmacological therapies in post stroke recovery: recommendations for future clinical trials. J. Neurol. 2014, 261:1461-1468.